Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment

ClinicalTrials.gov ID: NCT05318937

Public ClinicalTrials.gov record NCT05318937. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 7:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Parkinson's Disease Cognitive Impairment

Study identification

NCT ID
NCT05318937
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
86 participants

Conditions and interventions

Interventions

  • SAGE-718-matching placebo Drug
  • SAGE-718 Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2022
Primary completion
Jan 16, 2024
Completion
Feb 22, 2024
Last update posted
Sep 11, 2025

2022 – 2024

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
Sage Investigational Site Sun City Arizona 85351
Sage Investigational Site Little Rock Arkansas 72205
Sage Investigational Site Fresno California 93710
Sage Investigational Site Long Beach California 90806
Sage Investigational Site Los Angeles California 90048
Sage Investigational Site Reseda California 91335
Sage Investigational Site Sacramento California 95816
Sage Investigational Site Englewood Colorado 80113
Sage Investigational Site Vernon Connecticut 06066
Sage Investigational Site Boca Raton Florida 33431
Sage Investigational Site Boca Raton Florida 33486
Sage Investigational Site Hialeah Florida 33012
Sage Investigational Site Miami Florida 33032
Sage Investigational Site Orlando Florida 32789
Sage Investigational Site Port Orange Florida 32127
Sage Investigational Site Tampa Florida 33609
Sage Investigational Site Tampa Florida 33613
Sage Investigational Site Decatur Georgia 30030
Sage Investigational Site Chicago Illinois 60611
Sage Investigational Site Kansas City Kansas 66160
Sage Investigational Site Bloomington Minnesota 55425
Sage Investigational Site Las Vegas Nevada 89106
Sage Investigational Site Albany New York 12208
Sage Investigational Site New York New York 10019
Sage Investigational Site Stony Brook New York 11794-8121
Sage Investigational Site Williamsville New York 14221
Sage Investigational Site Woodmere New York 11598
Sage Investigational Site Raleigh North Carolina 27607
Sage Investigational Site Cincinnati Ohio 45221
Sage Investigational Site Columbus Ohio 43221
Sage Investigational Site Toledo Ohio 43614
Sage Investigational Site Memphis Tennessee 38157
Sage Investigational Site Nashville Tennessee 37232
Sage Investigational Site Houston Texas 77030
Sage Investigational Site San Antonio Texas 78229
Sage Investigational Site Burlington Vermont 05401
Sage Investigational Site Virginia Beach Virginia 23502
Sage Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05318937, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05318937 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →